Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Outlook Therapeutics stock prices $5M offering at $0.25 per share amid Nasdaq plunge and biotech funding squeeze
Outlook Therapeutics has priced a $5 million public offering of 20 million shares and warrants at $0.25 each, leading to a 39% stock drop due to dilution fears. The offering aims to address acute liquidity needs for the retina disease specialist as its ONS-5010/LYTENAVA product awaits US FDA approval, despite successful European launches. This move highlights the company’s financial strain and the high cost of capital for pre-revenue biotech firms.